Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Lipids

Citations 91-100 of 397 total displayed.

Past content (since Feb 1999):

Molecular Cardiology
Oxidized Lipid-Driven Chemokine Receptor Switch, CCR2 to CX3CR1, Mediates Adhesion of Human Macrophages to Coronary Artery Smooth Muscle Cells Through a Peroxisome Proliferator-Activated Receptor {gamma}–Dependent Pathway
Jana Barlic, Yuan Zhang, John F. Foley, and Philip M. Murphy
Circulation 2006;114:807-819; published online before print as doi:10.1161/CIRCULATIONAHA.105.602359 [Abstract] [Full text]  

Articles
Oxidized Lipid-Driven Chemokine Receptor Switch, CCR2 to CX3CR1, Mediates Adhesion of Human Macrophages to Coronary Artery Smooth Muscle Cells Through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway
Jana Barlic, Yuan Zhang, John F. Foley, and Philip M. Murphy
Circulation published August 14, 2006, doi:10.1161/CIRCULATIONAHA.105.602359 [Abstract]  

Clinician Update
Intravascular Ultrasound in Cardiovascular Medicine
Stephen J. Nicholls, E. Murat Tuzcu, Ilke Sipahi, Paul Schoenhagen, and Steven E. Nissen
Circulation 2006;114:e55-59e, doi:10.1161/CIRCULATIONAHA.106.637942 [Full text]  

AHA Scientific Statements
Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee
Alice H. Lichtenstein, Lawrence J. Appel, Michael Brands, Mercedes Carnethon, Stephen Daniels, Harold A. Franch, Barry Franklin, Penny Kris-Etherton, William S. Harris, Barbara Howard, Njeri Karanja, Michael Lefevre, Lawrence Rudel, Frank Sacks, Linda Van Horn, Mary Winston, and Judith Wylie-Rosett
Circulation 2006;114:82-96; published online before print as doi:10.1161/CIRCULATIONAHA.106.176158 [Abstract] [Full text]  

Surgery for Valvular Heart Disease
Metabolic Syndrome Is Associated With Faster Degeneration of Bioprosthetic Valves
Martin Briand, Philippe Pibarot, Jean-Pierre Després, Pierre Voisine, Jean G. Dumesnil, François Dagenais, and Patrick Mathieu
Circulation 2006;114:I-512-517I-, doi:10.1161/CIRCULATIONAHA.105.000422 [Abstract] [Full text]  

Articles
Diet and Lifestyle Recommendations Revision 2006. A Scientific Statement From the American Heart Association Nutrition Committee
Alice H. Lichtenstein, Lawrence J. Appel, Michael Brands, Mercedes Carnethon, Stephen Daniels, Harold A. Franch, Barry Franklin, Penny Kris-Etherton, William S. Harris, Barbara Howard, Njeri Karanja, Michael Lefevre, Lawrence Rudel, Frank Sacks, Linda Van Horn, Mary Winston, and Judith Wylie-Rosett
Circulation published June 21, 2006, doi:10.1161/CIRCULATIONAHA.106.176158 [Abstract]  

Articles
Diet and Lifestyle Recommendations Revision 2006. A Scientific Statement From the American Heart Association Nutrition Committee
Alice H. Lichtenstein, Lawrence J. Appel, Michael Brands, Mercedes Carnethon, Stephen Daniels, Barry Franklin, Penny Kris-Etherton, William S. Harris, Barbara Howard, Njeri Karanja, Michael Lefevre, Lawrence Rudel, Frank Sacks, Linda Van Horn, Mary Winston, and Judith Wylie-Rosett
Circulation published June 19, 2006, doi:10.1161/CIRCULATIONAHA.106.176158 [Abstract]  

Special Report
Preventive Cardiology by Lifestyle Intervention: Opportunity and/or Challenge?: Presidential Address at the 2005 American Heart Association Scientific Sessions
Robert H. Eckel
Circulation 2006;113:2657-2661, doi:10.1161/CIRCULATIONAHA.106.175744 [Full text]  

AHA/ACC Guideline
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith, Jr, Jerilyn Allen, Steven N. Blair, Robert O. Bonow, Lawrence M. Brass, Gregg C. Fonarow, Scott M. Grundy, Loren Hiratzka, Daniel Jones, Harlan M. Krumholz, Lori Mosca, Richard C. Pasternak, Thomas Pearson, Marc A. Pfeffer, and Kathryn A. Taubert
Circulation 2006;113:2363-2372, doi:10.1161/CIRCULATIONAHA.106.174516 [Full text]  

Coronary Heart Disease
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial
Michelle O’Donoghue, David A. Morrow, Marc S. Sabatine, Sabina A. Murphy, Carolyn H. McCabe, Christopher P. Cannon, and Eugene Braunwald
Circulation 2006;113:1745-1752; published online before print as doi:10.1161/CIRCULATIONAHA.105.612630 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40

* Subspecialty Collections Home

* Show  Lipids
 collections from other journals.

* Related collections:
 Etiology
 Acute coronary syndromes
 Acute myocardial infarction
 Arrhythmias, clinical electrophysiology, drugs
 Cardiac development
 Chronic ischemic heart disease
 Clinical genetics
 Epidemiology
 Heart failure
 Hypertension
 Hypertrophy
 Infectious endocarditis
 Lipids
 Myocardial cardiomyopathy disease
 Obesity
 Pericardial disease
 Peripheral vascular disease
 Pulmonary circulation and disease
 Remodeling
 Restenosis
 Valvular heart disease
 Other etiology